2013 - ISODP 2013 Congress


Oral Presentation 17 on Graft and Patient Outcomes 2

45.2 - Disqualification of a haemodynamically functional heart with LQTS syndrome - unjustified organ loss?

Presenter: Romuald, Bohatyrewicz, Szczecin, Poland
Authors: Romuald Bohatyrewicz, Maciej Zukowski, Carl Ludwig Fisher-Froelich, Maria Wujtewicz, Radoslaw Owczuk, Joanna Pastuszka-Solek, Jowita Biernawska, Agnieszka Zienciuk, Antoni Ottowicz, Katarzyna Kotfis, Anna Milecka


Disqualification of a haemodynamically functional heart with LQTS syndrome – unjustified organ loss?

Romuald Bohatyrewicz1,2,3,4,5, Maciej Zukowski1,2,3,4,5, Carl Ludwig Fisher-Froelich1,2,3,4,5, Maria Wujtewicz1,2,3,4,5, Radoslaw Owczuk1,2,3,4,5, Joanna Pastuszka-Solek1,2,3,4,5, Jowita Biernawska1,2,3,4,5, Agnieszka Zienciuk1,2,3,4,5, Antoni Ottowicz1,2,3,4,5, Katarzyna Kotfis1,2,3,4,5, Anna Milecka1,2,3,4,5

1Department of Anaesthesiology and Intensive Therapy, Pomeranian Medical University, Szczecin, Poland, 2Region Baden-Wuerttemberg , Deutsche Stiftung Organtransplanation, Stuttgart, Germany, 3Department of Anaesthesiology and Intensive Therapy, Medical University of Gdansk, Gdansk, Poland, 4Department of Cardiology and Electrotherapy, Medical University of Gdansk, Gdansk, Poland, 5Regional Transplant Coordination Center, Medical University of Gdansk, Gdansk, Poland

Long QT syndrome (LQTS) is a genetically determined ion channel disorder. It might be the reason of severe ventricular arrhythmias leading to sudden cardiac death. Early introduction of cardiopulmonary resuscitation may effect in a restoration of efficient circulation in some cases, however brain death due to anoxia is possible.

Case report

19 year old female suffered from recurrent syncopal attacks. She was admitted to the hospital following cardiac arrest at home in a mechanism of ventricular fibrillation. During in-hospital treatment an episode of the pulseless electrical activity with a short episode of nonsustained polymorphic ventricular tachycardia was observed. All brain stem reflexes slowly disappeared except for residual respiratory drive, which persisted until day 17th.  On 19th day patient was declared brain dead. Predonation echocardiography showed normal heart contractility - EF 55%. She was heamodynamically stable, RR-120/80mmHg, HR-106/min, without catecholamine infusion. Kidneys, corneas and aortal homograft were harvested. Heart was not transplanted due to suspicion of LQTS. Genetic studies, completed later, confirmed polymorphism KCNH2 gene and all family was included to program of sudden cardiac death prevention.

We presume that LQTS in brain dead patients as a result of cardiac arrest might be unexpectedly frequent, especially in a group of younger donors. Brain death may be the result of brain hypoxia after cardiac arrest in some cases and mechanical injuries due to syncopes in the others.

Current guidelines of the ISHLT do not recommend to transplant hearts with intractable ventricular arrhythmias [1]. LQTS obviously does not lead to intractable arrhythmias if earlier recognized and properly treated. So far, at least one case of unplanned but successful “LQTS heart” transplantation with subsequent ICD implantation has already been reported [2]. Probably many more were performed without such  knowledge. The authors of above mentioned publication would accept such heart for really sick patient [dr M. Shehata -  personal information]. 

 Conclusions

  1. Transplantation of “LQTS hearts” with concomitant LCD  implantation may be considered after proper risk benefit assessment in special cases.
  2. The clear opinion of the ISHLT concerning acceptance of “LQTS heart donors” is needed.


You must be logged in to view recordings

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi